Publications

Opportunities and challenges in applying microbiota to clinical cancer immunotherapy

 78
Opportunities and challenges in applying microbiota to clinical cancer immunotherapy

Tags:

Previous Article

Mitochondria keep immune cells “ready to respond”

Next Article

Microbiota in clinical cancer immunotherapy

Related Posts

Ganglioside GT1b prevents selective spinal synapse removal following peripheral nerve injury

Ganglioside GT1b prevents selective spinal synapse remo...

 104

Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system

Intravenous administration of blood–brain barrier-cross...

 147

Rev-erb-a antagonism in alveolar macrophages protects against pneumococcal infection in elderly mice

Rev-erb-a antagonism in alveolar macrophages protects a...

 130